← Leaderboards
Thomas Cardaci
University Of South Carolina At Columbia
$128,993
Attributed
$128,993
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$128,993 · 2
By mechanism
F99$79,462 · 1
F31$49,531 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Lorne J Hofseth$6,260,808
- Elizabeth Angela Murphy$6,337,319
- James A Carson$3,645,457
- Gabrielle Michelle Turner-McGrievy$12,474,516
- Fred Kinyuy Tabung$1,464,716
Others in their field
Other Rising Stars on “Obese Mice”
- Simon Vu · Equator Therapeutics, Inc.$3,142,274
- Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation$3,065,252
- Xiaobing Zhang · Florida State University$2,571,302
- Zhenying Nie · Oregon Health & Science University$2,470,126
- Arta Monir Monjazeb · University Of California At Davis$2,377,570
- Dale Adam Lauver · Michigan State University$2,357,673
Research focus
Obese MiceMuscle MitochondriaMitochondriaMetabolismMorphologyMuscle FunctionEpidemiologyFunctional DisorderMalignant NeoplasmsMetabolicMorbidity - Disease RateCachexiaMuscle FormCancer CachexiaBiogenesisEnzymesCancer PatientActivities Of Daily LivingLiteratureMaintenanceCancer TherapyCarcinogenesisMitochondrial DysfunctionObesity
Grant awards (4)
Microbiome-Mitochondrial Interactions Driving Cancer-Induced Cachexia in the Obese State$39,263
F99 · FY2025 · CA · contact PI
Microbiome-Mitochondrial Interactions Driving Cancer-Induced Cachexia in the Obese State$40,199
F99 · FY2024 · CA · contact PI
Impact of obesity on chemotherapy-induced muscle mitochondrial dysfunction$12,458
F31 · FY2024 · CA · contact PI
Impact of obesity on chemotherapy-induced muscle mitochondrial dysfunction$37,073
F31 · FY2023 · CA · contact PI